Fungal diseases in Africa: epidemiologic, diagnostic and therapeutic advances
Loading...
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Therapeutic Advances in Infectious Disease
Abstract
The spectrum of fungal diseases that affect
humans is broad, ranging from asymptomatic
superficial mycoses to deep systemic diseases
due to opportunistic or primary fungal pathogens.
1 Recently, the COronaVIrus Disease 2019
(COVID-19) pandemic has highlighted mucormycosis
as an important opportunistic fungal
disease, especially in patients with uncontrolled
diabetes mellitus and prolonged, high-dose corticosteroid
use.2
Fungal diseases substantially contribute to the
burden of diseases in Africa, mainly driven by
heavy affliction of poverty, tuberculosis (TB) and
human immunodeficiency virus (HIV) (Figure
1).3,4 Recent estimates of the burden of key fungal
diseases are summarized in Table 1.
The overarching aim of the special collection was
to provide a state-of-the-art overview of our current
understanding of various aspects of fungal
diseases in Africa. It was overwhelmingly successful
with a total of 14 high-quality submissions
summarized below.
Description
Keywords
Fungal diseases, Africa, Epidemiologic, Therapeutic advances
Citation
Bongomin, F., Kibone, W., Okot, J., Nsenga, L., Olum, R., & Baluku, J. B. (2022). Fungal diseases in Africa: epidemiologic, diagnostic and therapeutic advances. Therapeutic Advances in Infectious Disease, 9, 20499361221081441. DOI: 10.1177/ 20499361221081441